L- and DL- Phenylglycines to treat diseases or conditions attrib
L- and DL-Phenylglycines to treat a disease or condition attribu
L- and DL-Phenylglycines to treat diseases or conditions attribu
L- or DL-threo-3-(3,4-dihydroxyphenyl)serine for the treatment o
L-&bgr;-dioxolane uridine analogs and their pharmaceutical...
L-.alpha.-amino acids as transdermal penetration enhancers
L-.alpha.-glycerophosphoryl-D-myo-inositol for the treatment of
L-.beta.-dioxolane uridine analog administration for treating Ep
L-.beta.-dioxolane uridine analogs and methods for treating and
L-2',3'-dideoxy nucleoside analogs as anti-Hepatitis B (HBV) age
L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and
L-2'3',dideoxy nucleoside analogs as anti-hepatitus B (HBV) agen
L-2-oxothiazolidine-4-carboxylic acid derivatives and use thereo
L-3-hydroxymethyltyrosine and salts thereof for lowering blood p
L-654,040, antibacterial agent
L-arabino-disaccharides of anthracyclines, processes for...
L-arginine and phosphodiesterase (PDE) inhibitor synergism
L-Arginine D,L-pyroglutamate as a pharmaceutical agent having an
L-ascorbic acid 2-phosphate zinc salt and process for...
L-ascorbic acid and pectin composition